Dupont Capital Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-33,994
Closed -$1.28M – 1288
2019
Q4
$1.28M Hold
33,994
– – 0.03% 490
2019
Q3
$1.58M Sell
33,994
-2,860
-8% -$133K 0.04% 394
2019
Q2
$1.93M Buy
36,854
+1,973
+6% +$116K 0.04% 384
2019
Q1
$2.4M Buy
34,881
+12,098
+53% +$811K 0.05% 323
2018
Q4
$1.36M Buy
22,783
+10,733
+89% +$926K 0.03% 451
2018
Q3
$1.4M Buy
12,050
+3,444
+40% +$389K 0.03% 485
2018
Q2
$1.09M Buy
8,606
+961
+13% +$117K 0.03% 536
2018
Q1
$827K Buy
+7,645
New +$846K 0.02% 567

Other funds holding CLB

Dupont Capital Management's CLB Position: Q1 2020 in Review

Dupont Capital Management sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 33,994 shares — an estimated $1.28M sold.

Dupont Capital Management first reported a position in CLB in Q1 2018 and held it in 8 quarters. The position peaked at $2.4M in Q1 2019. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.

  • Dupont Capital Management reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
  • Dupont Capital Management sold 33,994 Core Laboratories shares in Q1 2020, an estimated $1.28M.
  • Dupont Capital Management first reported a position in Core Laboratories in Q1 2018 and held it in 8 quarters.
  • Dupont Capital Management's Core Laboratories position peaked at $2.4M in Q1 2019.
  • 207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.

Based on Dupont Capital Management's 13F filing for Q1 2020, filed 29 Apr 2020.